Drug Shortage Report for LODALIS

Last updated on 2023-12-08 History
Report ID 166024
Drug Identification Number 02432463
Brand name LODALIS
Common or Proper name LODALIS
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) COLESEVELAM HYDROCHLORIDE
Strength(s) 3.75G
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 30ct
ATC code C10AC
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2022-10-31
Actual start date 2022-10-31
Estimated end date
Actual end date 2023-12-01
Shortage status Resolved
Updated date 2023-12-08
Company comments Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-12-08 French Compare
v11 2023-12-08 English Compare
v10 2023-11-27 French Compare
v9 2023-11-27 English Compare
v8 2023-11-27 French Compare
v7 2023-11-27 English Compare
v6 2022-11-09 French Compare
v5 2022-11-09 English Compare
v4 2022-11-01 English Compare
v2 2022-08-03 French Compare
v3 2022-08-03 French Compare
v1 2022-08-03 English Compare

Showing 1 to 12 of 12